
Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.
Currently we only process 8-K, 6-K, Schedule 13G. We will support more forms in the future.
Filter by Form Type:
2025-12-19AKR8-KAcadia Realty Trust Appoints David Buell as Chief Accounting OfficerHIGH
Acadia Realty Trust announced the appointment of David Buell as its new Chief Accounting Officer, effective January 5, 2026. Buell, who has over 15 years of experience, including serving as Chief Accounting Officer at Kite Realty Group Trust and as a Senior Manager in KPMG's audit practice, will succeed Richard Hartman...
Mid CapREIT - RetailOfficer / Director Change
2025-12-19ACCS8-KForm 8-K Filing - ACCESS Newswire Inc.MEDIUM
On December 16, 2025, ACCESS Newswire Inc. announced an adjustment to its executive compensation. The Compensation Committee of the Board of Directors approved an increase in the annual base salary for Steven Knerr, the Chief Financial Officer. Effective January 1, 2026, Mr. Knerr's salary will rise from $200,000 to $2...
Nano CapAdvertising AgenciesOfficer / Director Change
2025-12-19ASNS8-KActelis Networks, Inc. Announces Public Offering of Common Stock and WarrantsHIGH
Actelis Networks, Inc. has announced a public offering of its common stock and warrants, aiming to raise approximately $5 million. The offering includes the sale of 4,352,500 shares of common stock, 1,897,500 pre-funded warrants, and 6,250,000 common warrants. The shares and accompanying common warrants are priced at $...
Nano CapCommunication EquipmentEquity Offering
2025-12-19ALCO8-KAlico, Inc. Declares Quarterly Cash DividendMEDIUM
Alico, Inc. announced that its Board of Directors has declared a cash dividend for the first quarter of fiscal year 2026. The dividend is set at $0.05 per share on the company's outstanding common stock. Shareholders of record as of January 2, 2026, will receive the dividend, with payments expected to be made on Januar...
Micro CapFarm ProductsShareholder Related
2025-12-19ALUR8-KAllurion Technologies, Inc. 2025 Annual Meeting of Stockholders SummaryHIGH
Allurion Technologies, Inc. held its 2025 Annual Meeting of Stockholders on December 18, 2025. Key outcomes included the re-election of Omar Ishrak, M.D., Douglas Hudson, and R. Jason Richey to the Board of Directors. Stockholders ratified the appointment of Deloitte & Touche LLP as the independent registered public ac...
Nano CapMedical DevicesShareholder Related
2025-12-19AEP8-KForm 8-K Filing: Special Equity Award for CEOHIGH
On December 18, 2025, American Electric Power Company, Inc. (AEP) announced a special equity award for its CEO, William J. Fehrman. This award is part of AEP's retention strategy and aims to align the CEO's compensation with the company's performance. The award includes $10,000,000 in performance shares, which will ves...
Mega CapUtilities - Regulated ElectricOfficer / Director Change
2025-12-19FOLD8-KAmicus Therapeutics, Inc. Merger Agreement with BioMarin Pharmaceutical Inc.HIGH
Amicus Therapeutics, Inc. has entered into an Agreement and Plan of Merger with BioMarin Pharmaceutical Inc. and its subsidiary, Lynx Merger Sub 1, Inc. The merger will result in Amicus Therapeutics becoming a wholly-owned subsidiary of BioMarin Pharmaceutical. Each share of Amicus common stock will be converted into $...
Mid CapBiotechnologyM&A / Divestiture
Sponsored
2025-12-19ARKO8-KARKO Corp. Files IPO Registration for ARKO PetroleumHIGH
ARKO Corp. announced on December 19, 2025, that its wholly owned subsidiary, ARKO Petroleum Corp. (APC), has filed a Registration Statement on Form S-1 with the SEC for a proposed initial public offering of APC's Class A common stock. APC will encompass ARKO's wholesale, fleet fueling, and GPMP segments. The company al...
Small CapSpecialty RetailEquity Offering
2025-12-19ACNT8-KAscent Industries Authorizes New Share Repurchase ProgramHIGH
Ascent Industries Co. announced that its Board of Directors has authorized a new stock repurchase program allowing for the repurchase of up to 2.0 million shares of its common stock over a two-year period ending December 16, 2027. This new program supersedes a previous authorization, under which nearly 75% of the share...
Micro CapSteelShareholder Related
2025-12-19ASPI8-KASP Isotopes Inc. 2025 Annual Meeting of StockholdersMEDIUM
ASP Isotopes Inc. held its 2025 Annual Meeting of Stockholders on December 18, 2025. Stockholders voted on three proposals. The first proposal concerned the election of two Class III Directors, Sipho N. Maseko and Todd Wider, M.D., for terms until the 2028 annual meeting. The second proposal was the ratification of Eis...
Small CapChemicalsOfficer / Director Change
2025-12-19AZO8-KAutoZone, Inc. 2025 Annual Shareholder Meeting ResultsMEDIUM
The 2025 Annual Meeting of Shareholders for AutoZone, Inc. was held on December 17, 2025. Shareholders elected 11 directors who will serve until the 2026 Annual Meeting. All director nominees received more votes in favor than against. The shareholders also ratified the appointment of Ernst & Young LLP as the company's ...
Mega CapAuto PartsShareholder Related
2025-12-19ABL8-KAbacus Global Management, Inc. Transfer of Listing to NYSEMEDIUM
Abacus Global Management, Inc. announced its decision to voluntarily withdraw the listings of its common stock and 9.875% Fixed Rate Senior Notes due 2028 from The Nasdaq Stock Market LLC. The company plans to transfer these listings to the New York Stock Exchange (NYSE). The delisting from Nasdaq is expected to occur ...
Small CapInsurance - LifeListing Compliance
2025-12-19ACET8-KAdicet Bio, Inc. 2025 Special Meeting of Stockholders SummaryMEDIUM
On December 19, 2025, Adicet Bio, Inc. held its 2025 Special Meeting of Stockholders. The primary agenda item was a vote on a reverse stock split, which was approved by the stockholders. The approved amendment to the Company’s Restated Certificate of Incorporation will combine outstanding shares of common stock into a ...
Micro CapBiotechnologyShareholder Related
2025-12-19ALT8-KAltimmune Announces Topline 48-Week Data from IMPACT Phase 2b TrialHIGH
Altimmune, Inc. announced positive topline results from the 48-week IMPACT Phase 2b trial of pemvidutide, a glucagon/GLP-1 dual receptor agonist, for patients with metabolic dysfunction-associated steatohepatitis (MASH). The trial demonstrated statistically significant improvements in key non-invasive tests (NITs) for ...
Small CapBiotechnologyoperation_related
Sponsored
2025-12-19ABCP8-KAmBase Corporation Enters Into Senior Promissory Note with CEOMEDIUM
AmBase Corporation has entered into a Senior Promissory Note with its Chairman, President, and CEO, Richard A. Bianco, for a loan of $300,000. The loan bears an interest rate of 6.5% per annum and is intended for working capital. The note is due either upon the Company receiving sufficient funds from any source (exclud...
Debt Financing
2025-12-19APTOF8-KAptose Biosciences Reschedules Special Meeting for Hanmi AcquisitionHIGH
Aptose Biosciences Inc. announced the rescheduling of its special shareholder meeting, originally set for January 16, 2026, to a later date in January 2026. This meeting is to approve the company's continuance from the Canada Business Corporations Act to the Business Corporations Act (Alberta) and its subsequent acquis...
M&A / Divestiture
2025-12-19ACRE8-KAmendment to Master Repurchase and Securities ContractMEDIUM
On December 18, 2025, Ares Commercial Real Estate Corporation (the Company), through its subsidiaries ACRC Lender W LLC, ACRC Lender W TRS LLC, ACRC Warehouse Holdings LLC, and ACRC 2017-FL3 Holder REIT LLC, entered into an amendment to the Third Amended and Restated Master Repurchase and Securities Contract with Wells...
Micro CapREIT - MortgageDebt Financing
2025-12-19BANX8-KArrowMark Financial Corp. Announces Direct Public Offering of Common StockHIGH
ArrowMark Financial Corp. (NASDAQ: BANX) has entered into a securities purchase agreement with certain investors for a direct public offering of 673,249 shares of its common stock at a price of $22.28 per share. The offering is expected to close on December 19, 2025. The net proceeds from the offering are approximately...
Micro CapAsset ManagementEquity Offering
2025-12-19AXTA8-KRetention Bonus Approvals in Connection with MergerHIGH
Axalta Coating Systems Ltd. has announced the approval of cash retention bonuses for key employees, including executive officers, in connection with its pending merger with AkzoNobel N.V. The bonuses, granted under specific retention agreements, are contingent upon continued employment through a defined retention perio...
Mid CapSpecialty ChemicalsOfficer / Director Change
2025-12-19AX8-KForm 8-K Filing - Departure of OfficerMEDIUM
On December 15, 2025, David Park resigned from his position as President, Head of Commercial Bank at Axos Bank, a subsidiary of Axos Financial, Inc. The resignation is effective at a later date and is not a result of any disagreements regarding the Company's matters. Derrick K. Walsh, EVP and Chief Financial Officer, s...
Mid CapBanks - RegionalOfficer / Director Change
2025-12-19BRN8-KBarnwell Industries, Inc. Reports Financial Results for Fiscal Year Ended September 30, 2025MEDIUM
Barnwell Industries, Inc. reported financial results for its fiscal year ended September 30, 2025. The company had revenue from continuing operations of $3,022,000 and a net loss from continuing operations of $2,429,000, or $0.24 per share, for the fourth quarter. For the fiscal year, revenue from continuing operations...
Nano CapOil & Gas E&PEarnings
Sponsored
2025-12-19BMRN8-KBioMarin Pharmaceutical Inc. Acquires Amicus Therapeutics, Inc.HIGH
BioMarin Pharmaceutical Inc. has entered into an Agreement and Plan of Merger with Amicus Therapeutics, Inc. for a cash acquisition of $14.50 per share. The merger, expected to close in the second quarter of 2026, will result in Amicus becoming a wholly owned subsidiary of BioMarin. This acquisition aims to accelerate ...
Large CapBiotechnologyM&A / Divestiture
2025-12-19BMNR8-KBitmine Immersion Technologies, Inc. Announces Annual Meeting Details and Encourages Stockholder ParticipationMEDIUM
Bitmine Immersion Technologies, Inc. has issued a press release on December 19, 2025, to invite stockholders to its annual meeting scheduled for January 15, 2026, in Las Vegas. The company is encouraging shareholders to cast their votes. The meeting agenda includes the election of eight directors, approval of a charter...
Mid CapCapital MarketsShareholder Related
2025-12-19BLKB8-KBlackbaud, Inc. - Amended and Restated BylawsMEDIUM
On December 17, 2025, Blackbaud, Inc. adopted amended and restated bylaws. These updates align the bylaws with Delaware law and current practices, enhance procedures for stockholder nominations and proposals, specify information requirements for proposing stockholders, and include technical and conforming changes. The ...
Mid CapSoftware - ApplicationBylaws Amendment
2025-12-19BCSS8-KAppointment of Independent DirectorMEDIUM
Bain Capital GSS Investment Corp. announced on December 18, 2025, the appointment of Michael E. Purves to its Board of Directors. Mr. Purves, 61, will also serve on the Company’s Audit Committee, Compensation Committee, and Nominating Committee. He is the Chief Executive Officer of Tallbacken Capital Advisors, LLC, and...
Officer / Director Change